Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Imugene completes enrolment in Phase lb trial of IMU-131

Histopathology of gastric adenocarcinoma representing a signet ring cell variant identified in an endoscopic biopsy specimen. Credit: KGH.



Go Top